Breaking News
July 18, 2018 - A 3-Pronged Plan to Cut Type 2 Diabetes Risk
July 18, 2018 - New clues to sepsis may speed diagnosis
July 18, 2018 - Stars of Stanford Medicine: Improving cardiovascular health in Africa and beyond
July 18, 2018 - Few tips to help avoid sunburns in summer
July 18, 2018 - Researchers develop 3D map of gene interactions that play key role in heart disease
July 18, 2018 - Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery
July 18, 2018 - Report warns of dog illness that can spread to owners
July 18, 2018 - A winning essayist’s tips for keeping track of scientific facts
July 18, 2018 - Researchers seek to understand role of APOE mutation in Alzheimer’s disease
July 18, 2018 - Animal studies reveal brain changes responsible for appetite effects of cannabis
July 18, 2018 - New ZEISS ZEN Intellesis machine allows segmentation of correlative microscopy
July 18, 2018 - Study findings highlight importance of early detection of SMA through newborn screening
July 18, 2018 - Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of Pixuvri (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
July 18, 2018 - Diabetes researchers find switch for fatty liver disease
July 18, 2018 - The future of the microbiome: A conversation
July 18, 2018 - States attacking ACA would hurt most if shield on preexisting conditions were axed
July 18, 2018 - Novel delivery system for bacteriophages could offer new way to battle lung infections
July 18, 2018 - PTSD may increase risk of stroke, heart attack in World Trade Center response crews
July 18, 2018 - Finding the right protective eyewear for young athletes
July 18, 2018 - Routine screening, treatment could help stem nationwide opioid epidemic
July 17, 2018 - AI and radar technologies could help diabetics manage their disease
July 17, 2018 - New Stanford algorithm could improve diagnosis of many rare genetic diseases
July 17, 2018 - Burdensome symptoms of eczema can lead to impaired quality of life, shows study
July 17, 2018 - Sartorius Stedim Biotech and Penn State partner to advance teaching, research in biotechnology
July 17, 2018 - Researchers map family trees of cancer cells to understand how AML responds to new drug
July 17, 2018 - Mortality from heart failure remains higher in women than men
July 17, 2018 - Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction
July 17, 2018 - AAP: Lawnmowers Pose Serious Injury Risk to Children
July 17, 2018 - Fewer U.S. kids are getting cavities
July 17, 2018 - Differences in brain’s reward circuit may explain social deficits in autism
July 17, 2018 - YCC researchers suggest promising treatment for two rare inherited cancer syndromes
July 17, 2018 - FAU and partners receive NIH research grant to shed light on sleep loss and metabolic disorders
July 17, 2018 - Advanced MRI technique predicts risk of disease progression in MS
July 17, 2018 - Health Tip: Microwave Safely – Drugs.com MedNews
July 17, 2018 - New target for treating heart failure identified
July 17, 2018 - Biodesign fellows simplify heart rhythm monitoring
July 17, 2018 - Study reveals new risk genes for allergic rhinitis
July 17, 2018 - Community college education can increase physician diversity and access to primary care
July 17, 2018 - Inflection Biosciences’ dual mechanism inhibitor shows promise as treatment for CLL
July 17, 2018 - Researchers uncover how cells invite corrupted proteins inside
July 17, 2018 - Large international study finds new risk genes for hay fever
July 17, 2018 - Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients
July 17, 2018 - New website aims to make yoga safer for everyone
July 17, 2018 - Long-term survival worse for black survivors of in-hospital cardiac arrest
July 17, 2018 - Stanford data analyst’s childhood inspires his research: A Q&A
July 17, 2018 - Preventability of hospital readmissions changes over time, study reveals
July 17, 2018 - Nursing notes can help predict if ICU patients will survive
July 17, 2018 - Most older adults with probable dementia found to be either undiagnosed or unaware of it
July 17, 2018 - Vallum receives FDA clearance to market PEEK spinal interbody fusion device
July 17, 2018 - Okayama University research could improve prognosis of diabetic kidney disease
July 17, 2018 - Researchers develop machine learning method to predict unknown gene functions of microbes
July 17, 2018 - Homogenous BTK occupancy assay used in tirabrutinib clinical studies
July 17, 2018 - Study identifies new genes linked to heart function and development
July 17, 2018 - NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology
July 17, 2018 - Improved methods to measure enterococci concentrations in recreational water
July 17, 2018 - White adolescent boys experiencing early puberty have high risk for substance use
July 17, 2018 - Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
July 17, 2018 - Roots of leukemia reveal possibility of predicting people at risk
July 17, 2018 - Summer med program embraces low-income students’ potential
July 17, 2018 - New research lays foundation to create standards for RNA sequencing
July 17, 2018 - CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought
July 17, 2018 - Democrats rally against threats to the ACA to block Trump’s Supreme Court nominee
July 17, 2018 - Staggering prices slow insurers’ coverage of CAR-T cancer therapy
July 17, 2018 - How proteins involved in neurodegeneration enter cells
July 17, 2018 - New super-resolution ‘nanoscope’ provides insight into progression of Alzheimer’s disease
July 17, 2018 - FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
July 17, 2018 - Uncovering the evolutionary history of IBD-associated colorectal cancer
July 17, 2018 - Is nutrition research dependable? Stanford’s John Ioannidis weighs in
July 17, 2018 - New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions
July 17, 2018 - Plant-based products fail to have positive impact on blood pressure during clinical studies
July 17, 2018 - Electronic system to speed up facial pain diagnosis may improve quality of life and save money
July 17, 2018 - Study delves into the role played by Protein Kinase C in synaptic plasticity
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - New AASM guideline recommends use of actigraphy for sleep disorders
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers

Advanced in vitro methodologies demonstrate new paradigms for toxicological testing

image_pdfDownload PDFimage_print

These techniques have significant ramifications for the widely recognized 3Rs of animal research: the replacement, reduction and refinement of animal use in scientific research. The presentation of these techniques and the results obtained was made at a dedicated session on the risk assessment of chemical mixtures at the recent TOXCON 2018 interdisciplinary toxicology conference in Stará Lesná, Slovakia.

 

“Humans are routinely exposed to many different chemicals, in the air we breathe, the water we drink, and the food and products we consume,” said Dr A. Wallace Hayes, University of South Florida and Michigan State University, and Chairperson of the session at TOXCON. “We need new approaches to testing to assess the health impacts of these complex chemical mixtures and a variety of models, from in silico to non-mammalian in vivo, are proving promising. PMI has demonstrated the significant potential of advanced in vitro methodologies in this area, which not only reduce the need for animal models but also offer more timely, robust, and human-specific scientific findings.”

 

Human cells grown in three-dimensional cultures were used in a series of studies comparing the effects of exposure to cigarette smoke with the aerosol of the Tobacco Heating System (THS 2.2), one of PMI’s Reduced-Risk Products. Using THS 2.2, tobacco is heated rather than burned, resulting in significantly reduced levels of harmful chemicals emitted and inhaled as compared with cigarette smoke. The three-dimensional configuration allowed primary epithelial cells taken from nasal, oral, and bronchial cavities to develop ‘organotypic’ tissues with complexity closely resembling that found in the human body. Cultures were then exposed to either cigarette smoke or THS 2.2 aerosol. Following these exposures, biological effects were assessed at various time-points and using an array of endpoints. Multiple experimental repetitions ensured results were robust, reliable and reproducible.

 

The biological effects of exposures in the nasal, oral, and bronchial studies were assessed using a combination of well-established in vitro testing endpoints such as deposition of toxic carbonyls, morphological alterations, and secretion of inflammatory mediators. Furthermore, collected data was also processed through a set of manually curated biological network models that are known to relate to respiratory disease. Biological impacts were then quantified, compared, and complemented by standard gene-set analysis. Combined results indicated that the biological impact of THS 2.2 aerosol is significantly reduced when compared with cigarette smoke and comparable to that of fresh-air exposure

 

Three-dimensional in vitro models can be further enhanced through the incorporation of small devices that reproduce the complex microenvironments of specific organs. These are often referred to as ‘organs-on-chips’. While they typically only represent a single organ, and therefore cannot be used to study the organ-to-organ interactions observed in the human body, PMI has developed a combined lung-liver-on-a-chip. This is an important development because while airborne compounds are absorbed by the lung, their true toxicity may only be fully realized following their metabolization by the liver. PMI has demonstrated the ability of the lung-liver-on-a-chip to hold both lung and liver tissues in a stable state for at least four weeks and has also confirmed its metabolic capacity.

 

“Testing the biological effects of exposure to heated tobacco aerosols requires the use of specialized test systems and exposure models,” said Dr Anita Iskandar, Senior Scientist, PMI. “The systems biology approaches that we have presented at TOXCON allow us to uncover biological effects at cellular and molecular levels which are undetectable using standard methods of toxicity testing. In collaboration with the wider scientific community, industry, and regulators, we are delighted to be developing the field of toxicological risk assessment and bringing it in line with the vision for 21st century toxicology set out by the US National Research Council.

 

To facilitate the reproducible and independent assessment of heated tobacco products, as well as other nicotine delivery systems such as e-cigarettes, PMI is making all their study data available on a dedicated database and searchable web portal called INTERVALS. Datasets are annotated for ease of use and full details of study designs and protocols are also included. The INTERVALS platform is a collaborative initiative that aims to develop a robust methodology for verifying scientific methods and results.

 

Tagged with:

About author

Related Articles